Historical record - last NADAC effective date: 11/19/2014
Product Information
CLINDAMYCIN HCL 300 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2716 per EA under NDC 63304069316. Its NADAC has been published 53 times since Nov 28, 2013.
FDA first approved this application on Feb 2, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304069316
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
11/19/2014
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065061FDA Approved
2/2/2001
TE Code
AB
On Market Since
3/23/2001
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has been published 53 times since Nov 28, 2013, and over the history we have for it it has risen 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2716 per EA |
|---|---|
| All-time high | $0.2751 (Feb 12, 2014) |
| All-time low | $0.2418 (Nov 28, 2013) |
| Median price | $0.2522 |
| Average price | $0.2559 |
| Largest weekly change | +10.8% (Nov 19, 2014) |
| Weeks tracked | 53 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+12.3%
Last surveyed Nov 26, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 300 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.2716 per EA (NDC 63304069316), effective Nov 26, 2014.
How has the price of CLINDAMYCIN HCL 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has risen 12.3%. It has been tracked across 53 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has ranged from a low of $0.2418 (Nov 28, 2013) to a high of $0.2751 (Feb 12, 2014), with a median of $0.2522 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 300 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN HCL 300 MG CAPSULE, is $0.1684 per EA — about 38% below CLINDAMYCIN HCL 300 MG CAPSULE.
Who manufactures CLINDAMYCIN HCL 300 MG CAPSULE?
CLINDAMYCIN HCL 300 MG CAPSULE (NDC 63304069316) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.